About our Program

Who may be at risk for a hereditary or familial cancer?

People with:

  • A personal or family history of early-onset cancer (e.g. younger than 45 years for breast cancer; younger than 50 years for colon or uterine cancer)
  • Multiple family members on the same side of the family with the same or related cancers
  • A family member with a diagnosis of more than one type of cancer
  • A personal or family history of breast, ovarian or pancreatic cancer who are of Jewish ancestry
  • A personal or family history of a rare type of cancer/tumor (e.g. breast cancer in a male; medullary thyroid cancer; a sebaceous carcinoma or adenoma)

Clinical Care 

Our clinical team is committed to providing a comprehensive plan to help assist patients and their families with all aspects of the risk assessment and testing process, surveillance, surgical decision-making, and follow-up care. 


Many exciting breakthroughs in genetics are expected in the coming years as a result of our improved understanding of the human genome. Cancer genetics is an exciting field that has shown great promise in the development of new cancer treatments and in cancer prevention. Our program is involved in several research projects aimed at helping to determine additional causes of hereditary cancers. 

Erin Hofstatter, MD 
Xavier Llor, MD, PhD 
Program Co-Directors 

Allen E. Bale, MD 
Scientific Director 

Karina Brierley, MS 
Chief Counselor

55 Church Street, Suite 402
New Haven, CT 06510
p (203) 764-8400 f (203) 764-8401

Questions about insurance, billing, or other FAQs